Apeiron RIA’s JPMorgan US Value Factor ETF JVAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.64M Sell
164,391
-10,980
-6% -$604K 2.47% 9
2026
Q1
$8.57M Sell
175,371
-8,491
-5% -$429K 1.99% 14
2025
Q4
$9.42M Sell
183,862
-31,925
-15% -$1.54M 1.91% 15
2025
Q3
$10.2M Sell
215,787
-12,325
-5% -$567K 2.29% 13
2025
Q2
$10.1M Buy
228,112
+12,270
+6% +$506K 2.6% 8
2025
Q1
$8.94M Buy
215,842
+4,029
+2% +$176K 2.7% 8
2024
Q4
$9.15M Buy
211,813
+54,705
+35% +$2.42M 2.56% 11
2024
Q3
$6.85M Buy
157,108
+16,925
+12% +$710K 1.96% 14
2024
Q2
$5.73M Buy
140,183
+22,410
+19% +$909K 1.76% 15
2024
Q1
$4.9M Buy
117,773
+16,278
+16% +$642K 1.42% 19
2023
Q4
$3.92M Buy
101,495
+18,290
+22% +$652K 1.22% 19
2023
Q3
$2.88M Buy
83,205
+16,762
+25% +$604K 0.98% 23
2023
Q2
$2.37M Buy
66,443
+28,183
+74% +$962K 0.81% 31
2023
Q1
$1.3M Buy
+38,260
New +$1.31M 0.45% 43

Other funds holding JVAL

Apeiron RIA's JVAL Position: Q2 2026 in Review

Apeiron RIA reduced its JPMorgan US Value Factor ETF (JVAL) stake by 6.3% in Q2 2026, selling an estimated $604K and leaving 164,391 shares worth $9.64M. The position accounts for 2.47% of the portfolio, ranked #9.

Apeiron RIA first reported a position in JVAL in Q1 2023 and has held it in 14 quarters since. The position peaked at $10.2M in Q3 2025. 168 funds tracked by Wall St. Rank hold JVAL as of Q2 2026.

  • Apeiron RIA held 164,391 shares of JPMorgan US Value Factor ETF worth $9.64M as of Q2 2026.
  • Apeiron RIA sold 10,980 JPMorgan US Value Factor ETF shares in Q2 2026, an estimated $604K.
  • JPMorgan US Value Factor ETF made up 2.47% of Apeiron RIA's portfolio in Q2 2026, its #9 holding.
  • Apeiron RIA first reported a position in JPMorgan US Value Factor ETF in Q1 2023 and has held it in 14 quarters since.
  • Apeiron RIA's JPMorgan US Value Factor ETF position peaked at $10.2M in Q3 2025.
  • 168 funds tracked by Wall St. Rank held JPMorgan US Value Factor ETF as of Q2 2026.

Based on Apeiron RIA's 13F filing for Q2 2026, filed 16 Jul 2026.